Other signaling pathways targeted in endometrial cancer include pathways like the mammalian target of rapamycin (mTOR), epidermal growth factor (EGF) and insulin-like growth factor (IGF), where receptors or kinases are targeted by specific inhibitors [105]. Here, MTOR is linked to endometrial cancer.